Lamond David 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 9:17 pm Purchase |
2021-03-04 | 13D | Quince Therapeutics, Inc. QNCX |
Lamond David | 4,460,154 10.100% |
2,411,216 (+117.68%) |
Filing |
| 2021-04-27 11:35 am Purchase |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
Lamond David | 2,048,938 6.900% |
93,773 (+4.80%) |
Filing |